Cargando…
Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma
BACKGROUND: Cancer recurrence is the important problem of cholangiocarcinoma (CCA) patients, lead to a very high mortality rate. Therefore, the identification of candidate markers to predict CCA recurrence is needed in order to effectively manage the disease. This study aims to examine the predictiv...
Autores principales: | Padthaisong, Sureerat, Thanee, Malinee, Namwat, Nisana, Phetcharaburanin, Jutarop, Klanrit, Poramate, Khuntikeo, Narong, Titapun, Attapol, Sungkhamanon, Sakkarn, Saya, Hideyuki, Loilome, Watcharin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008521/ https://www.ncbi.nlm.nih.gov/pubmed/32039729 http://dx.doi.org/10.1186/s12967-020-02243-w |
Ejemplares similares
-
A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma
por: Padthaisong, Sureerat, et al.
Publicado: (2020) -
In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines
por: Dokduang, Hasaya, et al.
Publicado: (2020) -
Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models
por: Thanee, Malinee, et al.
Publicado: (2021) -
CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression
por: Thanee, Malinee, et al.
Publicado: (2021) -
Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma
por: Kittirat, Yingpinyapat, et al.
Publicado: (2022)